Muscular Dystrophy (MD) is a group of disorders that cause progressive weakening and wasting away of muscle tissue. The disease is caused by a mutation of a gene that controls production of dystrophin, which is an essential protein needed to develop and maintain healthy muscle fibers. Symptoms of MD vary depending on the type, but can include progressive muscle weakness, loss of muscle mass, difficulty in walking, difficulty with balance and coordination, and eventual loss of independent mobility. While there is no single form of treatment that can fully address every symptom of MD, there are a variety of medical interventions and treatments that can improve quality of life. Medication can help with pain management, while physical and occupational therapy can help improve strength, flexibility, coordination and balance. Assistive devices such as wheelchairs and walkers can increase mobility, and braces or casts can be used to manage joint contractures. Specialized breathing and swallowing therapies may also be helpful in some cases. In addition to medical and therapeutic interventions, lifestyle modifications can also improve quality of life. People with MD should strive to maintain a healthy weight and incorporate regular exercise into their daily life. Aerobic activities such as swimming, biking or walking, as well as strength-building activities can help to improve muscle strength and stamina. Eating a nutritious diet and avoiding alcohol and tobacco can also be beneficial. Overall, living with MD can be challenging. However, with proper monitoring, lifestyle modifications and medical treatments, individuals affected by the disorder can still lead full and active lives. Through research and scientific advancements, the outlook for those impacted by MD continues to improve and more effective treatment options become available.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States